Court Rejects AbbVie Patent Suits, Boosting FTC Pay-for-Delay Claims

A federal judge in Pennsylvania threw out AbbVie’s patent suits against generic competitors, strengthening the Federal Trade Commission’s pay-for-delay case against the drugmaker.
Source: Generic Line